Based on evidence that BRAF is involved in the development of papillary carcinoma and in the progression to anaplastic cancer, BRAF is an attractive target in thyroid cancer, especially anaplastic and aggressive papillary subtypes where there is an urgent need for treatment. The gene discussed is BRAF; the disease is anaplastic cancer.